glp 1 and macular degeneration GLP-1 Drugs Linked to Higher Risk of Age-Related glp-1 and macular degeneration Glucagon‐like
Description
They are not for human consumption, medical treatment, diagnosis, or disease prevention
A nice mouse study
D., Hansen, T., & Bain, S
In this regard, one can consider the glucagon-like peptide-1 (GLP-1) receptor agonists, such as semaglutide and tirzepatide, and the potential applications of these agents for dementia and neurodegenerative disorders [44]
Both medications are metabolised through different pathwayssemaglutide by proteolytic enzymes and bupropion through hepatic CYP2B6 metabolism
The study is published in Nature Communications
